Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

One of the most common fears in cancer care? The biopsy #shorts

18 Feb 2026 · 1 min

Watch on YouTube

0:38

In this brief YouTube short, Dino Prato, NMD, addresses a frequent patient anxiety: whether to undergo a biopsy. He explains that modern precision oncology relies on both tissue and liquid biopsies to obtain detailed molecular information. By analyzing thousands of data markers and using conventional, integrative, on‑label, and off‑label targets, clinicians can tailor treatments precisely. Prato emphasizes that the insights from a biopsy are life‑changing, providing specific therapeutic targets and information that scans or tumor markers alone cannot deliver, ultimately improving patient outcomes.

Chapters

This is one of the most common fears I hear from patients. Should I even do the biopsy? And today we're going to answer this with precision Oncology. We want precise testing that often includes tissue biopsies and liquid biopsies. And then we use targets, conventional, integrative, on, off label, thousand plus data markers so we can treat patients with precision. And here's the key point. The information gained from a biopsy is life changing. It can change outcomes. It can give you the exact right targets when the information is used correctly. And it gives you so much more information just to scan, scan or a tumor marker. The information gained from a biopsy can change outcomes in ways that scans can never do.